Selection of appropriate empiric gram-negative coverage in a multinational pediatric burn hospital

Journal of Burn Care and Research

Volumn 34, Issue 1, 2013, Pages 203-210

  Friedstat, Jonathan S ^a,b   Moore, Molly E ^a,b   Weber, Joan M ^b   Fagan, Shawn P ^a,b   Goverman, Jeremy ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER LWOFFII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; BURN; BURN INFECTION; BURN PATIENT; CHILD; ELECTRIC BURN; FEMALE; GEOGRAPHIC ORIGIN; GRAM NEGATIVE BACTERIUM; HUMAN; KLEBSIELLA OXYTOCA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SCHOOL CHILD;

BURNS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS, PEDIATRIC; HUMANS; INCIDENCE; INTERNATIONALITY; LENGTH OF STAY; LINEAR MODELS; MALE; MASSACHUSETTS; PREVALENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WOUND INFECTION;

EID: 84873803803     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3182781829     Document Type: Article

References (29)

1. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-14.
2. Pittet D, Thiévent B, Wenzel RP, Li N, Auckenthaler R, Suter PM. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996;153:684-93.
3. Opal SM, Fisher CJ Jr, Dhainaut JF, et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 1997;25:1115-24.
4. Kumar A, Zarychanski R, Light B, et al.; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med 2010;38:1773-85.
5. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-74.
6. Komura S, Kurahashi K. Partial purification and properties of L-2,4-diaminobutyric acid activating enzyme from a polymyxin E producing organism. J Biochem 1979;86:1013-21.
7. Koyama Y, Kurosasa A, Tsuchiya A, Takakuta K. A new antibiotic "colistin" produced by spore-forming soil bacteria. J Antibiot (Tokyo) 1950;3:457-8.
8. Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gramnegative bacteria. Ann Pharmacother 1999;33:960-7.
9. Reed MD, Stern RC, O'Riordan MA, Blumer JL. The pharmacokinetics of colistin in patients with cystic fibrosis. J Clin Pharmacol 2001;41:645-54.
10. Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN. Emerging infections in burns. Surg Infect (Larchmt) 2009;10:389-97.
11. Keen EF 3rd, Robinson BJ, Hospenthal DR, et al. Prevalence of multidrug-resistant organisms recovered at a military burn center. Burns 2010;36:819-25.
12. Cho YS, Yim H, Yang HT, et al. Use of parenteral colistin for the treatment of multi-resistant Gram-negative organisms in major burn patients in South Korea. Infection 2011;40:27-33.
13. Healy DP, Sombun AD, Gardner JC, et al. Pharmacokinetics of colistin in an adolescent boy with extensive burn injury. J Burn Care Res 2011;32:e7-11.
14. Lipový B, Rihová H, Hanslianová M, Gregorová N, Suchánek I, Brychta P. Prevalence and resistance of Pseudomonas aeruginosa in severely burned patients: a 10-year retrospective study. Acta Chir Plast 2010;52:39-43.
15. Ganapathy H, Pal SK, Teare L, Dziewulski P. Use of colistin in treating multi-resistant Gram-negative organisms in a specialised burns unit. Burns 2010;36:522-7.
16. Rosanova M, Epelbaum C, Noman A, et al. Use of colistin in a pediatric burn unit in Argentina. J Burn Care Res 2009;30:612-5.
17. Trottier V, Segura PG, Namias N, King D, Pizano LR, Schulman CI. Outcomes of Acinetobacter baumannii infection in critically ill burned patients. J Burn Care Res 2007;28:248-54.
18. Goverman J, Weber JM, Keaney TJ, Sheridan RL. Intravenous colistin for the treatment of multi-drug resistant, gramnegative infection in the pediatric burn population. J Burn Care Res 2007;28:421-6.
19. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32.
20. Centers for Disease Control and Prevention. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. [Internet]. Available from: http://www.cdc. gov/nhsn/PDFs/pscManual/17pscNosInfDef-current. pdf;accessed May 25, 2012.
21. Peck MD, Weber J, McManus A, Sheridan R, Heimbach D. Surveillance of burn wound infections: a proposal for definitions. J Burn Care Rehabil 1998;19:386-9.
22. Forjuoh SN. Burns in low-and middle-income countries: a review of available literature on descriptive epidemiology, risk factors, treatment, and prevention. Burns 2006;32:529-37.
23. Taira BR, Singer AJ, Thode HC Jr, Lee C. Burns in the emergency department: a national perspective. J Emerg Med 2010;39:1-5.
24. DiGuiseppi C, Higgins JP. Interventions for promoting smoke alarm ownership and function. Cochrane Database Syst Rev 2001;(2):CD002246.
25. Pruitt BA Jr, Wolf SE, Mason AD Jr. Epidemiological, demographic and outcome characteristics of burn injury. In: Herndon DN, editor. Total burn care. 3rd ed. Philadelphia, PA: Saunders; 2007. p. 14-32.
26. McGowan JE Jr. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Infect Control 2006;34(5 Suppl 1):S29-37; discussion S64-73.
27. Quale J, Bratu S, Landman D, Heddurshetti R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis 2003;37:214-20.
28. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41:848-54.
29. Landman D, Bratu S, Alam M, Quale J. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B. J Antimicrob Chemother 2005;55:954-7.